elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital.
.
speaking on behalf of the family after the inquest, mrs cavanagh's son vincent said the coroner vindicated their need to raise concerns about the way in which their mother was cared for.
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
.